TL;DR
This paper presents the first high-resolution cryo-EM structures of the full-length glycoprotein hormone receptor (LHCGR) in both inactive and active states, revealing a novel "push and pull" mechanism for hormone-induced activation. These structures provide critical insights into how hormones like LH and CG trigger cellular signaling and offer a foundation for developing new therapeutic drugs.
What Problem Does This Paper Address?
Glycoprotein hormones, such as Luteinizing Hormone (LH) and Chorionic Gonadotropin (CG), are crucial for human reproduction and are targets for important therapeutic drugs. These hormones signal by binding to their receptor, LHCGR, which is a G protein-coupled receptor (GPCR). While the structures of some GPCRs and hormone-receptor interactions are known, the precise mechanism by which the large extracellular domain (ECD) of LHCGR, upon hormone binding, transmits a signal across the transmembrane domain (TMD) to activate intracellular G proteins has remained elusive. Understanding this process is vital for deciphering signaling dysfunctions and for designing small molecule drugs that can mimic or block these hormones' actions.
Methods
The researchers employed cryo-electron microscopy (cryo-EM) to determine the structures of the full-length LHCGR in complex with its ligands and signaling partners. This involved:
- Protein Expression and Purification: Developing robust methods to express and purify the full-length LHCGR, its Gs protein partner, and the hormones (CG) or small molecule agonists (Org43553). This was a significant challenge due to the complexity of these membrane protein complexes.
- Cryo-EM Data Collection: Acquiring high-resolution electron microscopy images of the purified complexes.
- Image Processing and Map Construction: Utilizing advanced computational pipelines (e.g., RELION, CryoSPARC) to process the raw images, classify particles, and reconstruct 3D density maps of the complexes.
- Model Building and Refinement: Docking known protein structures and building de novo models into the cryo-EM density maps, followed by rigorous refinement and validation.
- Molecular Dynamics (MD) Simulations: Performing simulations to investigate the dynamic behavior of the receptor and its interactions with ligands and membranes, providing insights into the activation process.
- Functional Assays (cAMP Response Assay): Measuring the receptor's activity by quantifying the cellular production of cyclic AMP (cAMP) in response to different hormone or agonist concentrations, and assessing the impact of specific mutations.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- "Push and Pull" Activation Mechanism: The most striking insight is the proposed "push and pull" mechanism. The bound hormone (CG) "pushes" the ECD away from the membrane, while an extended hinge loop "pulls" it, leading to a significant rotation and stabilization of the receptor in an active conformation.
- Tethered Agonist Role of P10 Region: A conserved 10-residue fragment (P10) in the hinge region acts as a "tethered agonist," directly inducing conformational changes in the TMD and facilitating G-protein coupling. This is a novel mechanism for receptor activation.
- Allosteric Agonist Binding Site: The small molecule agonist Org43553 binds to a distinct pocket within the TMD, not at the hormone-binding site on the ECD. This binding stabilizes the active conformation by interacting with the P10 region.
- Monmeric Nature of Active Complex: Contrary to some previous proposals for related receptors, the active LHCGR-Gs complex is observed to be monomeric, suggesting that the rigid ECD-TMD interface may prevent dimerization.
- Structural Basis for Specificity: The detailed interactions reveal how the unique β-subunits of different glycoprotein hormones confer specificity for their respective receptors.
Key Results
- High-Resolution Structures: The paper reports four cryo-EM structures of LHCGR: two wildtype (inactive and active states) and two constitutively active mutants, one of which is bound to the allosteric agonist Org43553. Resolutions range from 3.18 Å to 4.3 Å.
- ECD Rotation: Hormone binding induces a ~45° upward rotation of the LHCGR ECD relative to the inactive state.
- TMD Conformational Changes: The active state shows significant outward movement of TM6 (up to 12.3 Å), along with movements in TM5 and TM7, consistent with class A GPCR activation paradigms.
- Org43553 Mechanism: Org43553 stabilizes the active conformation by binding to a TMD pocket and interacting with the P10 region.
- Mutant Analysis: Functional assays confirm the importance of key residues in the hinge loop (e.g., Y331) for receptor activation, supporting the proposed push-and-pull model.
Limitations and Future Work
- In Vitro System: The structures were determined using purified components and expressed in insect cells, which may not fully recapitulate the native cellular environment.
- Dynamic Nature: While cryo-EM provides static snapshots, the dynamic aspects of receptor activation and G-protein coupling are complex and may require further investigation using techniques like molecular dynamics simulations.
- Drug Design Implications: The structures provide a strong foundation for structure-based drug design of small molecule modulators for LHCGR, aiming to treat endocrine disorders. Future work will likely focus on developing more potent and selective agonists and antagonists.
- Conservation Across Family: The authors suggest that the conserved activation mechanisms observed in LHCGR are likely applicable to other glycoprotein hormone receptors, opening avenues for broader therapeutic development.
Summary updated